Antimicrobial Resistance (AMR)
Antimicrobial resistance (AMR) is a growing global health threat, rendering common infections harder to treat and undermining advances in medicine. Driven by factors like overuse of antibiotics and poor infection control, AMR demands urgent action through strengthened stewardship and global cooperation to prevent a post-antibiotic era.
79
Member Organizations
Stronger
Together for Impact
16
Countries Represented
Evidence
Policy in Action
Objectives
Strengthen Antimicrobial Stewardship
Promote responsible and evidence-based use of antimicrobials across human, animal, and environmental health.
Prevent Antimicrobial Resistance
Support stronger infection prevention, control, surveillance, and measures that reduce the emergence and spread of resistant infections.
Advance AMR Policy and Advocacy
Translate scientific evidence and community perspectives into practical policy recommendations and coordinated advocacy.
Improve Access to Diagnostics and Treatment
Promote equitable access to quality diagnostics, appropriate antimicrobial treatment, and essential health technologies.
Strengthen One Health Collaboration
Connect stakeholders across human, animal, and environmental health to develop coordinated responses to AMR.
Mobilise Sustainable Action
Support sustainable financing, research, innovation, and international cooperation to address AMR as a long-term global health threat.
Leadership
Olufunbi Olaoye
Committee Manager
AMR
Members
Palpouguini Lompo
Researcher
IRSS Clinical Research Unit
Abdul Ghafur
Infectious Diseases Consultant
AMR Declaration Trust
Margaret Happy
Uganda Country Lead
AFROCAB
Andrew Bowskill
Co-chair
MTP Connect
Guest
Javier Aquiles Hidalgo Acosta
Specialist in critical medicine
Independent
Richard Lupasu Lupasu
Immunization Expert
World Health Organization
Priorities
Strengthen Antimicrobial Stewardship
Strengthen AMR Surveillance
Advance Research and Innovation
Secure Sustainable AMR Financing
Improve Prevention and Infection Control
Strengthen Global AMR Policy
Facts
More than 4.7 Million Deaths
Bacterial antimicrobial resistance was associated with over 4.7 million deaths in 2021.
1 in 6 Bacterial Infections Resistant
Around one in six bacterial infections worldwide was resistant to antibiotics in 2023.
Resistance Is Rising Worldwide
Antibiotic resistance rose in over 40% of combinations monitored by WHO from 2018–2023.
The Economic Cost Is Enormous
Resistant infections could cost US$412 billion annually in treatment by 2035.
Events
WORLD HEALTH SUMMIT 2025 SIDE EVENT: Push, Pull, Partner: Building a Global AMR Incentive Ecosystem
October 14, 2025 at 2:00:00 AM
Berlin
WORLD HEALTH SUMMIT 2025 SIDE EVENT: Push, Pull, Partner: Building a Global AMR Incentive Ecosystem
October 14, 2025 at 2:00:00 AM
Berlin